Results 1 to 10 of about 210 (78)

Efficacy of Credelio Quattro™ (Lotilaner, Moxidectin, Pyrantel, Praziquantel) and Credelio™ (Lotilaner) Against Longhorned Tick, Haemaphysalis longicornis,-Induced Infestations on Dogs [PDF]

Parasites and Vectors
Background Haemaphysalis longicornis, the longhorned tick, is an invasive tick species that has been identified in increasing numbers and regions across the USA.
Scott Wiseman, Lisa Young
exaly   +5 more sources

Efficacy of Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) and Credelio™ (Lotilaner) Chewable Tablets in the Prevention of Borrelia burgdorferi Transmission From Infected Ixodes scapularis in Dogs [PDF]

Parasites and Vectors
Background Borrelia burgdorferi, the causative agent of Lyme disease, is a zoonotic vector-borne pathogen transmitted by various Ixodes tick species. Lyme disease, while commonly asymptomatic, can induce fever and intermittent lameness in dogs.
Scott Wiseman, Lisa Young, Abdelmoneim Mansour   +2 more
exaly   +5 more sources

Efficacy Evaluation of Lotilaner (Credelio™) in Experimentally Induced Otodectes cynotis Infestations in Cats [PDF]

Parasites and Vectors
Background The ear mite, Otodectes cynotis, is pathogenic, highly contagious and a global cause of otitis externa and pruritus in cats and dogs. The present study evaluated the efficacy of a single oral application of lotilaner flavoured chewable tablets
Bettina Schunack, Friederike Kramer
exaly   +5 more sources

Safety of Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) in Homozygous MDR1-Mutant Collie Dogs [PDF]

Parasites and Vectors
Background Multidrug resistance-1 (MDR1) mutant dogs have diminished or lack P-glycoprotein (Pgp) expression at the blood–brain barrier and are therefore more susceptible to neurotoxicity caused by macrocyclic lactones and other Pgp substrates due to ...
Scott Wiseman, Kari L Riggs
exaly   +5 more sources

Long-Term Safety of Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets), a Novel Orally Administered Combination Endectocide for Dogs [PDF]

Parasites and Vectors
Background The combination of lotilaner, moxidectin, praziquantel, and pyrantel pamoate (Credelio Quattro) is a novel systemic endectocide that provides month-long effectiveness in dogs after a single oral treatment.
Scott Wiseman, Kari L Riggs
exaly   +5 more sources

Safety of Credelio Quattro™ (Lotilaner, Moxidectin, Praziquantel, and Pyrantel Chewable Tablets) in Dogs Infected With Adult Heartworms (Dirofilaria immitis) [PDF]

Parasites and Vectors
Background Credelio Quattro (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) is a novel endectocide for monthly oral administration in dogs.
Scott Wiseman, Kari L Riggs
exaly   +5 more sources

Efficacy of a Novel Chewable Tablet (Credelio Quattro™) Containing Lotilaner, Moxidectin, Praziquantel, and Pyrantel Against Toxocara canis and Toxascaris leonina Infections in Dogs [PDF]

Parasites and Vectors
Background Roundworms such as Toxascaris leonina and Toxocara canis are routinely diagnosed in dogs globally, especially in dogs 6 months of age or younger.
Craig R Reinemeyer, Scott Wiseman, Lisa Young   +2 more
exaly   +6 more sources

Effectiveness of Credelio® Plus, a Novel Chewable Tablet Containing Milbemycin Oxime and Lotilaner for the Treatment of Larval and Immature Adult Stages of Toxocara canis in Experimentally Infected Dogs [PDF]

Parasites and Vectors, 2021
Background The ascarid, Toxocara canis, is a common and important zoonotic intestinal nematode parasite that infects dogs globally. An effective treatment that kills any pre-patent stages of immature T.
Dwight Bowman, Daniel E Snyder, Craig R Reinemeyer   +2 more
exaly   +6 more sources

Field Study to Investigate the Effectiveness and Safety of a Novel Orally Administered Combination Drug Product Containing Milbemycin Oxime and Lotilaner (Credelio® Plus) Against Natural Flea and Tick Infestations on Dogs Presented as Veterinary Patients in Europe [PDF]

Parasites and Vectors, 2021
Background A pivotal randomised, blinded, positive-controlled, multicentre, European field study was conducted to evaluate the effectiveness and safety of a novel combination tablet of lotilaner and milbemycin oxime (Credelio® Plus) administered orally ...
Daniel E Snyder, Scott Wiseman
exaly   +6 more sources

Field Study to Investigate the Effectiveness and Safety of a Novel Orally Administered Combination Drug Product Containing Milbemycin Oxime and Lotilaner (Credelio® Plus) Against Natural Intestinal Nematode Infections in Dogs Presented as Veterinary Patients in Europe [PDF]

Parasites and Vectors, 2021
Background A randomised, blinded, positive controlled, multicentre, Good Clinical Practice-compliant, pivotal field study was conducted to evaluate the effectiveness and safety of a new combination of lotilaner + milbemycin oxime tablets (Credelio® Plus;
Daniel E Snyder, Scott Wiseman
exaly   +6 more sources